Answers are grounded in this paper and cite their sources.
Retrospective cohort analysis finds surgery improves cancer-specific survival in older adults with right-sided colon cancer, suggesting clinical benefits.
Introduction Right-sided colon cancer (RCC) is common among older adults and represents a major clinical burden in this population. However, substantial competing mortality and the lack of competing-risk analyses in prior studies have obscured the cancer-specific benefit of surgery. Methods We conducted a retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) database (2010-2015), including patients aged ≥75 years with RCC. To minimize baseline imbalances, a 1:1 propensity-score–matched (PSM) cohort was constructed. Survival was assessed using Kaplan–Meier methods for overall and cancer-specific survival and competing-risk analyses for cancer-specific death (CSD) and other-cause death (OCD). Independent predictors of CSD were identified using multivariable Fine–Gray regression, and a competing-risk nomogram was developed and internally validated for individualized risk prediction. Results Among 46,932 eligible patients, 1:1 propensity-score matching with exact T and M stage matching yielded a balanced cohort of 2,892 patients (1,446 per group). In the matched cohort, surgery was associated with significantly improved overall and cancer-specific survival. Competing-risk analyses showed that the 5-year cumulative incidence of CSD was 20.4% in the surgery group versus 63.9% in the non-surgery group (Gray’s test P < 0.001), while OCD was 31.7% versus 29.6% (Gray’s test P < 0.001). In multivariable Fine–Gray regression, surgery remained the strongest independent protective factor for CSD (sHR 0.18, 95% CI 0.16–0.19; P < 0.001). Sensitivity analysis excluding T1 tumours showed that the association between surgery and improved survival remained consistent. The resulting competing-risk nomogram showed acceptable discrimination and overall calibration, and decision curve analysis suggested potential net clinical benefit across a range of thresholds. Conclusion In elderly patients with RCC, our findings are consistent with a cancer-specific survival benefit of surgery.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: